• Login
    View Item 
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles 2017
    • View Item
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles 2017
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Puskas, J.D.
    Bavaria, J.E.
    Svensson, L.G.
    Date
    2017
    Journal
    European Journal of Cardio-thoracic Surgery
    Publisher
    European Association for Cardio-Thoracic Surgery
    Type
    Article
    
    Metadata
    Show full item record
    See at
    https://www.doi.org/10.1093/ejcts/ezx158
    Abstract
    OBJECTIVES: The COMMENCE trial was conducted to evaluate the safety and effectiveness of a novel bioprosthetic tissue for surgical aortic valve replacement (AVR). METHODS: Patients underwent clinically indicated surgical AVR with the Carpentier-Edwards PERIMOUNT™ Magna Ease™ aortic valve with RESILIA™ tissue (Model 11000A) in a prospective, multinational, multicentre (n = 27), single-arm, FDA Investigational Device Exemption trial. Events were adjudicated by an independent Clinical Events Committee; echocardiograms were analysed by an independent Core Laboratory. RESULTS: Between January 2013 and February 2016, 689 patients received the study valve. Mean age was 67.0 ± 11.6 years; 71.8% were male; 26.3% were New York Heart Association Class III/IV. Mean STS PROM was 2.0 ± 1.8 (0.3–17.5). Isolated AVR was performed in 59.1% of patients; others had additional concomitant procedures, usually CABG. Thirty-day outcomes for all patients included all-cause mortality 1.2%, thromboembolism 2.2%, bleeding 0.9%, major paravalvular leak 0.1% and permanent pacemaker implantation 4.7%. Median intensive care unit and hospital length of stay were 2 (range: 0.2–66) and 7 days (3.0–121.0), respectively. At 2 years, New York Heart Association class improved in 65.7%, effective orifice area was 1.6 ± 0.5 cm2; mean gradient was 10.1 ± 4.3 mmHg; and paravalvular leak was none/trivial in 94.5%, mild in 4.9%, moderate in 0.5% and severe in 0.0%. One-year actuarial freedom from all-cause mortality for isolated AVR and for all patients was 98.2% and 97.6%, respectively. Two-year actuarial freedom from mortality in these groups was 95.3% and 94.3%, respectively. CONCLUSIONS: These data demonstrate excellent early safety and effectiveness of aortic valve replacement with a novel bioprosthetic tissue (RESILIA™). Copyright The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
    Keyword
    Aortic valve replacement
    Bioprosthetic valves
    RESILIATM
    Tissue
    Identifier to cite or link to this item
    https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046985935&doi=10.1093%2fejcts%2fezx158&partnerID=40&md5=9737a94dd400e8415673b84a987b0862; http://hdl.handle.net/10713/10016
    ae974a485f413a2113503eed53cd6c53
    10.1093/ejcts/ezx158
    Scopus Count
    Collections
    UMB Open Access Articles 2017

    entitlement

    Related articles

    • The sutureless aortic valve at 1 year: A large multicenter cohort study.
    • Authors: Fischlein T, Meuris B, Hakim-Meibodi K, Misfeld M, Carrel T, Zembala M, Gaggianesi S, Madonna F, Laborde F, Asch F, Haverich A, CAVALIER Trial Investigators.
    • Issue date: 2016 Jun
    • TRANSFORM (Multicenter Experience With Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement) US clinical trial: Performance of a rapid deployment aortic valve.
    • Authors: Barnhart GR, Accola KD, Grossi EA, Woo YJ, Mumtaz MA, Sabik JF, Slachman FN, Patel HJ, Borger MA, Garrett HE Jr, Rodriguez E, McCarthy PM, Ryan WH, Duhay FG, Mack MJ, Chitwood WR Jr, TRANSFORM Trial Investigators.
    • Issue date: 2017 Feb
    • Outcomes of surgical aortic valve replacement using Carpentier-Edwards PERIMOUNT bioprosthesis series in elderly patients with severe aortic valve stenosis: a retrospective cohort study.
    • Authors: Nishioka N, Yamada A, Ujihira K, Iba Y, Maruyama R, Hatta E, Kurimoto Y, Nakanishi K
    • Issue date: 2016 Dec
    • Intermediate-term outcomes of aortic valve replacement using a bioprosthesis with a novel tissue.
    • Authors: Johnston DR, Griffith BP, Puskas JD, Bavaria JE, Svensson LG, COMMENCE Trial Investigators.
    • Issue date: 2020 Feb 21
    • Primary safety and effectiveness feasibility study after surgical aortic valve replacement with a new generation bioprosthesis: one-year outcomes.
    • Authors: Bartuś K, Litwinowicz R, Kuśmierczyk M, Bilewska A, Bochenek M, Stąpór M, Woźniak S, Różański J, Sadowski J, Kapelak B
    • Issue date: 2018
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.